Tuberculous pericarditis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(6 intermediate revisions by the same user not shown)
Line 22: Line 22:
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! rowspan="4"  style="background: #4479BA; color: #FFFFFF; text-align: center;|Diseases
! rowspan="4"  style="background: #4479BA; color: #FFFFFF; text-align: center;|Diseases
|
| colspan="6" rowspan="1"  style="background: #4479BA; color: #FFFFFF; text-align: center;|'''Clinical manifestations'''
| colspan="6" rowspan="1"  style="background: #4479BA; color: #FFFFFF; text-align: center;|'''Clinical manifestations'''
|
|
! colspan="7" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;|Para-clinical findings
|
! colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
| colspan="1" rowspan="4"  style="background: #4479BA; color: #FFFFFF; text-align: center;|'''Gold standard'''
| colspan="1" rowspan="4"  style="background: #4479BA; color: #FFFFFF; text-align: center;|'''Gold standard'''
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;|Additional findings
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;|Additional findings
|-
|-
| rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;|'''History'''
| colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;|'''Symptoms'''
| colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;|'''Symptoms'''
! colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
! colspan="5" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
|-
|-
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;|Lab Findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;|Imaging
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;|Histopathology
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;|Histopathology
|-  
|-  
Line 41: Line 44:
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;|JVP
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;|JVP
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Heart/Lung sounds
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Heart/Lung sounds
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Hepatosplenomegaly
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Hepatomegaly
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Splenomegaly
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Lab 1
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Lab 1
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Lab 2
! style="background: #4479BA; color: #FFFFFF; text-align: center;|CXR
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Lab 3
! style="background: #4479BA; color: #FFFFFF; text-align: center;|CT Scan
! style="background: #4479BA; color: #FFFFFF; text-align: center;|CT Scan
! style="background: #4479BA; color: #FFFFFF; text-align: center;|MRI
! style="background: #4479BA; color: #FFFFFF; text-align: center;|MRI
Line 50: Line 53:
|-
|-
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! colspan="17" |Constrictive pericarditis
! colspan="18" |Constrictive pericarditis
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Tuberculosis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Tuberculosis<ref name="pmid5410398">{{cite journal |vauthors=Rooney JJ, Crocco JA, Lyons HA |title=Tuberculous pericarditis |journal=Ann. Intern. Med. |volume=72 |issue=1 |pages=73–81 |date=January 1970 |pmid=5410398 |doi=10.7326/0003-4819-72-1-73 |url=}}</ref><ref name="pmid15138314">{{cite journal |vauthors=Cherian G |title=Diagnosis of tuberculous aetiology in pericardial effusions |journal=Postgrad Med J |volume=80 |issue=943 |pages=262–6 |date=May 2004 |pmid=15138314 |pmc=1742992 |doi=10.1136/pgmj.2003.013664 |url=}}</ref><ref name="pmid15138314">{{cite journal |vauthors=Cherian G |title=Diagnosis of tuberculous aetiology in pericardial effusions |journal=Postgrad Med J |volume=80 |issue=943 |pages=262–6 |date=May 2004 |pmid=15138314 |pmc=1742992 |doi=10.1136/pgmj.2003.013664 |url=}}</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Close contact with TB+ person
| style="background: #F5F5F5; padding: 5px;" |+
| style="background: #F5F5F5; padding: 5px;" |+
| style="background: #F5F5F5; padding: 5px;" |+
| style="background: #F5F5F5; padding: 5px;" |±
| style="background: #F5F5F5; padding: 5px;" |↑
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Friction rub]]
* [[Heart sounds#Fourth%20heart%20sound%20S4|S4]]
* Distant [[heart sounds]]
* Fine/coarse [[crackles]] upon auscultation of the lung
* Pericardial knock
* Pericardial rub
| style="background: #F5F5F5; padding: 5px;" |+
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Miled anemia
* Leukocytosis
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Pleural effusion
* Pericardial calcification
* Pericardial thickening
* Pericardial effusion
* Evidence of pulmonary TB
* Enlarged cardiac silhouette
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Calcification]] of the [[pericardium]]
* Thickened [[pericardium]]
* [[Pericardial effusion]]
* Back flow of blood into the [[IVC]] and [[hepatic veins]] (in contrast [[CT scan]])
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Pericardial effusion
* Pericardial thickening
* Mediastinal and tracheobronchial lymphadenopathy (with hilar sparing)
* Bowing of the interventricular septum toward the left ventricle during diastole
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Pericardial effusion]]
* [[Pericardial]] thickening
* Increased [[right ventricular]] dimensions
* Decreased [[left ventricular]] dimensions
* Abnormal septal motion
* Flattening of the [[left ventricular]] posterior wall during diastol
* Dilated [[inferior vena cava]]
* Dilated [[atrium]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Acid fast bacilli
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Pericardiocentesis]]
* [[Pericardial]] [[biopsy]] (If we can't find acid fast bacilli in sputum or [[pericardial fluid]])
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Idiopathic/Viral
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Idiopathic/Viral
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Recent common cold
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |+
| style="background: #F5F5F5; padding: 5px;" |±
| style="background: #F5F5F5; padding: 5px;" |±
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 89: Line 129:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Post cardiac surgery
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Post cardiac surgery
| style="background: #F5F5F5; padding: 5px;" |
* Cardiac surgery
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 107: Line 149:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Post radiation
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Post radiation
| style="background: #F5F5F5; padding: 5px;" |
* Radiation
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 125: Line 169:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Connective tissue disease
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Connective tissue disease
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 144: Line 189:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Malignancy
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Malignancy
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* History of known malignancy
| style="background: #F5F5F5; padding: 5px;" |+
| style="background: #F5F5F5; padding: 5px;" |±
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Ankle edema
| style="background: #F5F5F5; padding: 5px;" |↑
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Pericardial knock
* [[Pericardial rub]]
* Distant [[heart sounds]]
| style="background: #F5F5F5; padding: 5px;" |+
| style="background: #F5F5F5; padding: 5px;" |−
| style="background: #F5F5F5; padding: 5px;" |Increased:
* Creatine kinase
* Cardiac troponin-I
* [[LDH]]
* Serum [[myoglobin]]
* [[SGOT]] ([[AST]])
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Pericardial calcifications
* Enlarged cardiac silhouette
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 153: Line 218:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Mesothelioma]]<ref name="MRimesothelioma1">Radiographic findings of mesothelioma. Dr Bruno Di Muzio and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/articles/mesothelioma. Accessed on February 8, 2015</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Mesothelioma]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 179: Line 239:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Chronic [[renal failure]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Chronic [[renal failure]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 197: Line 258:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Asbestosis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Asbestosis
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 214: Line 276:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! colspan="17" |Restrictive cardiomyopathy
! colspan="18" |Restrictive cardiomyopathy
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Amyloidosis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Amyloidosis<ref name="pmid24847009">{{cite journal| author=Falk RH, Quarta CC, Dorbala S| title=How to image cardiac amyloidosis. | journal=Circ Cardiovasc Imaging | year= 2014 | volume= 7 | issue= 3 | pages= 552-62 | pmid=24847009 | doi=10.1161/CIRCIMAGING.113.001396 | pmc=4118308 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24847009  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 235: Line 298:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sarcoidosis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sarcoidosis
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 253: Line 317:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemochromatosis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemochromatosis
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 271: Line 336:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sclerodema
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sclerodema
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 289: Line 355:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Endomyocardial fibrosis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Endomyocardial fibrosis
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 307: Line 374:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Carcinoid heart disease
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Carcinoid heart disease
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 325: Line 393:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Post radiation
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Post radiation
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 343: Line 412:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Diabetic cardiomyopathy
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Diabetic cardiomyopathy
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 361: Line 431:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hurler
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hurler
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 379: Line 450:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Gaucher
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Gaucher
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 397: Line 469:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Fabry
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Fabry
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 415: Line 488:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Wegener
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Wegener
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 433: Line 507:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Metastatic malignancies
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Metastatic malignancies
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |

Latest revision as of 15:52, 4 April 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview


Differentiating [Disease name] from other Diseases

[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].

OR

[Disease name] must be differentiated from [differential dx1], [differential dx2], and [differential dx3].

OR

As [disease name] manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].

Differentiating [disease name] from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]

On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
History Symptoms Physical examination
Lab Findings Imaging Histopathology
Chest pain Fever Cough Edema/Ascites JVP Heart/Lung sounds Hepatomegaly Splenomegaly Lab 1 CXR CT Scan MRI Echo/Sono
Constrictive pericarditis
Tuberculosis[1][2][2]
  • Close contact with TB+ person
+ + + ± +
  • Miled anemia
  • Leukocytosis
  • Pleural effusion
  • Pericardial calcification
  • Pericardial thickening
  • Pericardial effusion
  • Evidence of pulmonary TB
  • Enlarged cardiac silhouette
  • Pericardial effusion
  • Pericardial thickening
  • Mediastinal and tracheobronchial lymphadenopathy (with hilar sparing)
  • Bowing of the interventricular septum toward the left ventricle during diastole
  • Acid fast bacilli
Idiopathic/Viral
  • Recent common cold
+ ± ±
Post cardiac surgery
  • Cardiac surgery
Post radiation
  • Radiation
Connective tissue disease
Malignancy
  • History of known malignancy
+ ±
  • Ankle edema
+ Increased:
  • Pericardial calcifications
  • Enlarged cardiac silhouette
Mesothelioma[3]
Chronic renal failure
Asbestosis
Restrictive cardiomyopathy
Amyloidosis[4]
Sarcoidosis
Hemochromatosis
Sclerodema
Endomyocardial fibrosis
Carcinoid heart disease
Post radiation
Diabetic cardiomyopathy
Hurler
Gaucher
Fabry
Wegener
Metastatic malignancies

References

  1. Rooney JJ, Crocco JA, Lyons HA (January 1970). "Tuberculous pericarditis". Ann. Intern. Med. 72 (1): 73–81. doi:10.7326/0003-4819-72-1-73. PMID 5410398.
  2. 2.0 2.1 Cherian G (May 2004). "Diagnosis of tuberculous aetiology in pericardial effusions". Postgrad Med J. 80 (943): 262–6. doi:10.1136/pgmj.2003.013664. PMC 1742992. PMID 15138314.
  3. Radiographic findings of mesothelioma. Dr Bruno Di Muzio and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/articles/mesothelioma. Accessed on February 8, 2015
  4. Falk RH, Quarta CC, Dorbala S (2014). "How to image cardiac amyloidosis". Circ Cardiovasc Imaging. 7 (3): 552–62. doi:10.1161/CIRCIMAGING.113.001396. PMC 4118308. PMID 24847009.

Template:WH Template:WS